US Patent 11560392 Boron-containing compounds
Patent 11560392 was granted and assigned to VenatoRx Pharmaceuticals on January, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11560392 Boron-containing compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
